All PlansCoverageMedium impact
Recall: Clobetasol
UPMC Health Plan·PA · Dermatology, Pharmacy·Pharmacy
Effective date
Jan 1, 2022
We identified it
Aug 7, 2026
Summary
Taro Pharmaceuticals has recalled one lot (AC13786, expiration 12/2022) of Clobetasol Propionate Ointment USP 0.05% in 60g tubes due to potential safety concerns. The billing team must identify and flag any claims associated with this specific lot and coordinate with providers to ensure affected patients are notified and alternative treatments are prescribed.
Action Required
Immediately: Billing and clinical teams must cross-reference pharmacy records to identify any patients who received Clobetasol Propionate Ointment USP 0.05% from lot AC13786 (expiration 12/2022). Flag these claims in the billing system and notify providers to contact affected patients per FDA recall protocols. Do not process reimbursement claims for this recalled lot. Coordinate with pharmacy to document recall response and maintain records for compliance.